LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: The AccuSpan HCV RNA linearity panel (Photo courtesy of SeraCare).
Image: The AccuSpan HCV RNA linearity panel (Photo courtesy of SeraCare).
SeraCare Life Sciences (Milford, MA, USA) promoted its new AccuSpan HCV RNA Linearity Panel at the 70th AACC Annual Scientific Meeting and Clinical Lab Expo held in Chicago, USA from July 29 - August 2.

SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. The company supports the diagnostic testing industry with biological materials to develop, validate, and challenge today's most trusted serology and molecular infectious disease assays. With recent rapid advances in clinical genomics and precision diagnostics, SeraCare has developed a leading portfolio of highly flexible, patient-like reference materials and lab QC programs to support advanced diagnostic applications such as next-generation sequencing and digital PCR.

At AACC 2018, SeraCare promoted its new AccuSpan HCV RNA Linearity Panel, a safe, non-infectious panel that is compatible with leading PCR-based applications and features eight members in K3EDTA plasma. The eight-member panel is made from serial dilutions of high titer recombinant Hepatitis C virus (genotype 1b) with established reactivity for HCV RNA and one negative member. The panel consists of seven members representing serial log dilutions of AccuPlex recombinant HCV in negative diluent and one negative member prepared from the diluent. The diluent was prepared from pooled K3EDTA plasma that was filtered through a 0.2 micron filter with sodium azide (0.09%) added as a preservative.

The panel can be used for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, verifying lot changes, performing linearity studies, or whenever there are indications of possible assay deterioration.

Related Links:
SeraCare Life Sciences

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more